By Thomas D. Reed, PhD
BIOCONTRACT SERVICES:
A Supplement to BPJ Volume 3, Issue 1 (January/February 2004)
A significant percentage of new pharmaceutical commercialization activities now focus on biological-based therapeutics. This increasing demand for biologicals necessitates the continued expansion and technological improvement of bioprocessing activities. Bioprocessing plays a critical role throughout the entire drug commercialization process…
Citation: Reed TD. Outsourcing Molecular Biology Tasks: A Valuable Business Tool for Accelerating Bioprocessing R&D. BioProcess J, 2004; 3(1, Suppl. 1): S25-30. https://doi.org/10.12665/BCS1.Reed
Posted online July 19, 2026